Animal Cell Technology: From Target To Market: Proceedings Of The 17th Esact Meeting Tylosand, Sweden, June 10-14, 2001: Pr by E. Lindner-OlssonAnimal Cell Technology: From Target To Market: Proceedings Of The 17th Esact Meeting Tylosand, Sweden, June 10-14, 2001: Pr by E. Lindner-Olsson

Animal Cell Technology: From Target To Market: Proceedings Of The 17th Esact Meeting Tylosand…

byE. Lindner-OlssonEditorN. Chatzissavidou, E. Lüllau

Paperback | November 5, 2012

Pricing and Purchase Info

$619.85 online 
$730.50 list price save 15%
Earn 3,099 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This book is the lasting product, a resource of up-to-date information in the scientific literature for the field of animal cell technology, as it was presented during a pleasant and stimulating meeting in Tylösand, Sweden, in June 2001. The title of the meeting, From Target to Market, indicates the usefulness of Animal Cell Technology during all steps in the pharmaceutical development process. Following the biotech products reaching the market, it shows an upward trend in the contribution of biotech products to total New Molecular Entity output in the nineties, which continued until 1996 when biotech represented 25% of the annual output. Since then the proportion has been decreasing. A perceived hurdle from a market perspective is that a protein per definition is biodegradable and thus requires intravenous, or for some drugs subcutaneous administration. New promising administration technologies such as pulmonary delivery were highlighted at this meeting. The emphasis on project selection prior to entry in the development phase has triggered a portfolio management using more extensive preclinical data before a development decision is taken. Animal cells have become a very important tool in the drug discovery process. The next generation of products will evolve from applications such as gene therapy, novel vaccines, cell therapy, and gene regulation. Animal cell technology has a major role to play in the post-sequence era.
Title:Animal Cell Technology: From Target To Market: Proceedings Of The 17th Esact Meeting Tylosand…Format:PaperbackDimensions:595 pages, 24 × 16 × 0.01 inPublished:November 5, 2012Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:940103897X

ISBN - 13:9789401038973

Look for similar items by category:

Reviews

Table of Contents

17th ESACT Meeting Committees. ESACT Executive Committee. Sponsors. Companies Participating in the Trade Exhibition. List of Participants. Introduction - From Target to Market. Acknowledgements. I. Identification of Drugs and Drug Targets. II. Expression Systems for Target and Drug Production. III. Cell Physiology and Metabolism. IV. Process Technology. V. Changes in Regulatory Environment. VI. New Technologies for Administration of Cell Derived Proteins. VII. Novel Prophylactic and Therapeutic Approaches Based on Animal Cells or Nucleic Acids. Author Index. Subject Index.